Abnormalities, Multiple: Clinical Trials

3 trials for Abnormalities, Multiple, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Terminated 3

Follow Abnormalities, Multiple: new trials by email Literature Review of Abnormalities, Multiple trials Research Report on Abnormalities, Multiple

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients
Liquid stable levothyroxine (L-T4) Tirosint-SOL, Oral tablet levothyroxine (L-T4) - Hypothyroidism, Trisomy 21
Phase 4TerminatedChildren's Mercy Hospital Kansas City62021-01-182023-09-13
Liraglutide Use in Prader-Willi Syndrome
Liraglutide - Diabetes Mellitus Type 2, Prader Willi Syndrome
Phase 4TerminatedVancouver General Hospital12012-02-012015-12-09
Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis
Azithromycin, Telithromycin - Maxillary Sinusitis
Phase 4TerminatedCPL Associates1922005-12-012007-10-31

Narrower conditions

Diabetes Mellitus, Type 2 (1)  ·  Down Syndrome (1)  ·  Focal Facial Dermal Dysplasias (1)  ·  Hypothyroidism (1)  ·  Maxillary Sinusitis (1)  ·  Prader-Willi Syndrome (1)  ·  Sinusitis (1)

Broader conditions

Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Chromosome Disorders (2)  ·  Endocrine System Diseases (2)  ·  Intellectual Disability (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Diabetes Mellitus (1)  ·  Ectodermal Dysplasia (1)  ·  Glucose Metabolism Disorders (1)  ·  Imprinting Disorders (1)  ·  Infections (1)

Interventions

Azithromycin (1)  ·  Liraglutide (1)  ·  Thyroxine (1)  ·  telithromycin (1)

Sponsors

CPL Associates (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Vancouver General Hospital (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Jason Kong, MD, FRCPC (1)  ·  Jerome J Schentag, Pharm.D. (1)  ·  Joseph Paladino, Pharm.D. (1)